Vaccine Design and Testing – News and Features

Researchers have engineered an enzyme to produce synthetic genetic material, advancing the discovery of new therapeutics for cancer and autoimmune, metabolic and infectious diseases.

This article explores the revolution in new drug modalities and the challenges around effective data strategies to support AI efforts.

Recovery from COVID-19 infection can have a protective effect against the worst effects of flu, and this memory response comes from an unexpected corner of the immune system.

A study reveals that natural immunity gained from previous influenza infections enhances immune responses to subsequent vaccinations. This finding suggests that individuals who contract the flu may benefit in their battle against future strains.

Bioprocessing involves the production of a high-value-added product from a living source. In this article, the stages of bioprocessing are described, with a focus on the central piece of this concept: the bioreactor.

Researchers developed the LASSARAB vaccine, using a deactivated rabies virus to protect against Lassa fever. In preclinical trials, it prevented severe disease and death in animals.

Around 300,000 people die from hepatitis C every year. A new study is the first to map the protein complex that enables the virus to infect our cells, potentially paving the way for an effective vaccine.

The monoclonal antibody SC27 effectively neutralizes numerous SARS-CoV-2 variants and related coronaviruses. SC27 targets multiple sites on the spike protein, showing broad protection in lab tests and animal models.

Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, which could better protect the population against current and future variants.

A pilot study identified that stress, BMI, exercise, and hormonal birth control influence COVID-19 vaccine side effects. Notably, exercise impacts side effects differently between doses.